All systems operational
For Researchers For Publishers Login Register
Home Publications Saudi Pharmaceutical Journal
Q1 2026

Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring

Mohammad Alsharhan · Omar S. Alkhezi · Osamah M. Alfayez
10.1007/s44446-026-00067-1 389 Views 0 Citations
0
Citations
389
Views
Abstract not available for this publication.
Cite this Article (APA)
Mohammad, A., Omar, S. A., Osamah, M. A. (2026). Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-026-00067-1
Related Papers
Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery
Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024
40
cites
395
Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems
Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024
30
cites
391
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024
26
cites
394
Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …
Faisal Imam; Sayantan Mukhopadhyay; Preeti Kothiyal; Samiyah Alshehri; Khalid Sa · 2024
24
cites
392
Access
View Full Text via DOI
Published in
ISSN 1319-0164
Quartile Q1
AMS Score 100
Field Medicine & Health Sciences
Publisher Elsevier / Saudi Pharmaceutical Soc
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 23 Jul 2026